Shivam Chemicals holds 16th AGM, approves FY26 results
- Shivam Chemicals held its 16th AGM on September 21, 2026
- Shareholders adopted audited standalone and consolidated financials for FY26
- Director Shivam Vasant was reappointed by rotation
- Statutory and secretarial audit reports had no adverse remarks

*this image is generated using AI for illustrative purposes only.
Shivam Chemicals Limited concluded its 16th Annual General Meeting on September 21, 2026. The gathering focused on approving the audited financial statements for the fiscal year ended March 31, 2026, and addressing routine corporate governance matters.
The meeting was held at the company’s registered office in Mumbai. Sanjiv Girdharlal Vasant, Managing Director, chaired the proceedings. He welcomed members, board directors, and representatives from the statutory and secretarial auditors.
Key Resolutions Passed
Shareholders approved two ordinary resolutions during the session:
- Adoption of the audited standalone and consolidated financial statements along with the Directors’ Report for FY26.
- Reappointment of Shivam Vasant as a director, who retires by rotation and offered himself for reappointment.
Mayuri Vasant proposed the first resolution, seconded by Shivam Vasant. Soham Vasant proposed the second resolution, seconded by Rajshree Vasant.
Governance and Compliance
Sanam Umbargikar, partner at M/s. DSM & Associates, served as the scrutinizer for the voting process. Members cast their votes via ballot paper. The company received no proxies for the meeting.
Statutory registers, including the Register of Members and Register of Directors’ Shareholding, were made available for electronic inspection throughout the event. Both the Statutory Audit Report and Secretarial Audit Report contained no adverse observations or disqualifications.
The meeting concluded at 11:45 am.
Historical Stock Returns for Shivam Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.17% | 0.0% | 0.0% | -6.24% | 0.0% | +142.51% |
How might the approved FY26 financial results influence Shivam Chemicals' dividend policy or capital allocation strategy for the upcoming fiscal year?
What specific growth initiatives or capacity expansion plans is the management expected to prioritize following the reappointment of key directors?
Given the clean audit reports, are there any pending regulatory compliance issues or environmental mandates that could impact operations in the near term?






























